| 000 | 01726cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030628.0 | ||
| 008 | 120528s2012 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2012.Ru.I | ||
| 100 | 0 | _aRuddy Moneer Abdalrahman | |
| 245 | 1 | 0 |
_aImprovement of physicochemical properties and bioavailability of etodolac / _cRuddy Moneer Abdalrahman ; Supervised Mahmoud M. Ghorab , Hussein O. Ammar |
| 246 | 1 | 5 | _aتحسين الخصائص الفيزيوكيميائية و التوافر الحيوي لعقار الإيتودولاك |
| 260 |
_aCairo : _bRuddy Moneer Abdalrahman , _c2012 |
||
| 300 |
_a215 P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aEtodolac (Lodine®) is a non-steroidal anti-inflammatory drug (NSAID). S-(+)-Etodolac has been widely applied in the treatment of inflammatory arthritis such as rheumatoid arthritis, gout and in osteoarthritis and has been shown to be efficacious and well tolerated. Although traditionally employed in the treatment of arthritis, NSAIDS have provided an effective alternative approach to analgesics in the management of mild to moderate pain in several other painful conditions such as low back pain | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBioavailability | |
| 653 | 4 | _aEtodolac | |
| 653 | 4 | _aPhysicochemical | |
| 700 | 0 |
_aHussein Osman Ammar , _eSupervisor |
|
| 700 | 0 |
_aMahmoud Mohamed Ghorab , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c38676 _d38676 |
||